[1]
Q. Zhou, “CRISPR/Cas9 in Antibody Engineering: Advances in Cell Line Optimization and Therapeutic Applications”, AJST, vol. 18, no. 1, pp. 57–62, Dec. 2025, doi: 10.54097/6hzmgm61.